The Ratio of CD8 to Treg Tumor Infiltrating Lymphocytes Is Associated with Neoadjuvant Cisplatin Based Chemotherapy Response in Patients with Muscle Invasive Urothelial Carcinomas of the Bladder

被引：0
作者：
Baras, Alexander
Drake, Charles
Liu, Jen-Jane
Gandhi, Nilay
Kates, Max
Hoque, Mohamed
Meeker, Alan
Hahn, Noah M.
Schoenberg, Mark
Taube, Janis
Bivalacqua, Trinity J.
Netto, George J.
机构：
[1] Johns Hopkins, Baltimore, MD USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
856
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
[31]   Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer [J].
Razzaghdoust, Abolfazl ;
Ghajari, Mahdi ;
Basiri, Abbas ;
Torbati, Peyman Mohammadi ;
Jafari, Anya ;
Fattahi, Mohammad Reza ;
Salahi, Maryam ;
Mofid, Bahram .
INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (03) :274-281
[32]   Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy [J].
Robins, Dennis ;
Matulay, Justin ;
Lipsky, Michael ;
Meyer, Alexa ;
Ghandour, Rashed ;
DeCastro, Guarionex ;
Anderson, Christopher ;
Drake, Charles ;
Benson, Mitchell ;
McKiernan, James M. .
UROLOGY, 2018, 111 :116-121
[33]   Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder [J].
Karaoglu, Aziz ;
Nieh, Peter ;
Canter, Daniel ;
Master, Viraj A. ;
Carthon, Bradley ;
Harris, Wayne ;
Shelton, Joseph ;
Rossi, Peter John ;
Jani, Ashesh B. ;
Khan, Mohammad K. ;
Osunkoya, Adeboya O. ;
Ogan, Ken ;
Pattaras, John ;
Ritenour, Chad ;
Kucuk, Omer .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[34]   CD3high and FoxP3- tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder [J].
Sun, Zi-Jun ;
Zhao, Jing-Wen ;
Zhao, Ming ;
Chen, Yuan ;
Zhang, Xin ;
Li, Hai-Chang ;
Wu, Guo-Qing ;
Zhang, Da-Hong .
ANTI-CANCER DRUGS, 2023, 34 (07) :844-851
[35]   Immune-related biomarkers associated with pathologic complete response (pCR) to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer undergoing cystectomy [J].
Ascierto, Maria L. ;
Mendoza-Valderrey, Alberto ;
Choe, Jane ;
Kessler, Daria M. ;
Li, Xinmin ;
Linehan, Jennifer A. ;
Twardowski, Przemyslaw W. .
CANCER RESEARCH, 2023, 83 (07)
[36]   Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer [J].
Mendoza-Valderrey, Alberto ;
Choe, Jane ;
Kessler, Daria M. ;
Jimenez, Gianna ;
Li, Xinmin ;
Kolker, Steven ;
Allen, Warren ;
Linehan, Jennifer A. ;
Twardowski, Przemyslaw W. ;
Ascierto, Maria Libera .
CANCER MEDICINE, 2024, 13 (15)
[37]   IDENTIFICATION OF MOLECULAR BIOMARKERS OF CISPLATIN-BASED CHEMOSENSITIVITY IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER [J].
Shah, Paras ;
Kozel, Zachary ;
Lee, Annette ;
Korsunsky, Ilya ;
Shih, Andrew ;
Yaskiv, Oksana ;
Vira, Manish ;
Bradley, Thomas ;
Zhu, Xinhua .
JOURNAL OF UROLOGY, 2017, 197 (04) :E1196-E1197
[38]   Impact of sarcopenia for patients with localized muscle invasive bladder cancer treated by neoadjuvant cisplatin based chemotherapy and radical cystectomy. [J].
Billon, Emilien ;
Regnier, Pierre ;
De Luca, Valeria ;
Brunelle, Serge ;
Walz, Jochen ;
Dermeche, Slimane ;
Guerin, Mathilde ;
Vicier, Cecile ;
Maubon, Thomas ;
Rybikowski, Stanislas ;
Branger, Nicolas ;
Fakhfakh, Sami ;
Pignot, Geraldine ;
Gravis, Gwenaelle .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[39]   The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+and CD8+) on Chemotherapy Response in Colorectal Cancer Patients [J].
Lukman, Kiki ;
Septianto, Rhandy ;
Rudiman, Reno ;
Ruchimat, Tommy ;
Sribudiani, Yunia ;
Nugraha, Prapanca ;
Primastari, Etis ;
Budiman, Deny .
CANCER MANAGEMENT AND RESEARCH, 2025, 17 :197-209
[40]   Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, doxorubicin hydrochloride, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle-invasive urothelial cell carcinoma of the bladder [J].
Wright, Jonathan Lawrence ;
Lee, Franklin ;
Harris, William Proctor ;
Cheng, Heather H. ;
Zhao, Song ;
Champion, Thomas ;
Gore, John L. ;
Dean, James ;
Porter, Michael P. ;
Yu, Evan Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345